← Back to headlines
Aprea Therapeutics Expands Patent Portfolio for Precision Oncology
Biotech firm Aprea Therapeutics has announced the addition of 58 patents to its intellectual property portfolio. The expansion strengthens the company’s development pipeline for targeted cancer therapies.
28 Aug, 12:15 — 28 Aug, 12:20
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
investing-comtaiwan-news
Right
Far R
Geographic diversity— 2 regions9/34
US1Taiwan1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
investing-com1d ago
Aprea Therapeutics reports patent portfolio of 58 patents
By Investing.com
Read full article →taiwan-newsMostly Factual1d ago
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs - Taiwan News
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs Taiwan News
Read full article →Coverage Timeline
First report: taiwan-news · 28 Aug, 12:15|Full coverage: 2 · 6m|Window: 6m
Left-leaningCenterRight-leaning
